AIA, RIA
The presence of circulating anti-insulin antibodies in insulin treated diabetics is estimated on a semi-quantitative basis, by the determination of the binding of 125I-Tyr-A14-insulin to the serum fraction precipitated by the polyethylene glycol (PEG) with gamma globulins.
Hey, it seems that you’re connected from United States.
For registration requirements in countries outside of European market, please contact regulatory.affairs@diasource.be.